Systemic drug interactions with topical glaucoma medications

Steve L. Gerber, Louis Cantor, D. Craig Brater

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Topically administered ophthalmic medications are capable of attaining clinically important serum concentrations, as evidenced by the variety of systemic side effects they can produce. These drugs are therefore also capable of interacting with other drugs administered orally and intravenously. This is especially important when medications are administered to an elderly population, who are often receiving multiple medications. The Physician's Desk Reference and the United States Pharmacopeia Drug Information directory contain numerous warnings of potential interactions between topical glaucoma medications and systemically administered drugs. Unfortunately, literature supporting such interactions is limited, both in quantity and quality, being anecdotal in many cases. This report summarizes available information regarding the nonocular interactions between topical ophthalmic glaucoma medications and other systemically administered medications. Clinical evidence of these interactions is lacking in many cases.

Original languageEnglish
Pages (from-to)205-218
Number of pages14
JournalSurvey of Ophthalmology
Volume35
Issue number3
DOIs
StatePublished - 1990

Fingerprint

Drug Interactions
Glaucoma
Pharmaceutical Preparations
Directories
Pharmacopoeias
Physicians
Serum
Population

Keywords

  • adrenergic agonist
  • beta-adrenergic antagonist
  • drug interactions
  • glaucoma medications
  • parasympathomimetic agent

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Systemic drug interactions with topical glaucoma medications. / Gerber, Steve L.; Cantor, Louis; Brater, D. Craig.

In: Survey of Ophthalmology, Vol. 35, No. 3, 1990, p. 205-218.

Research output: Contribution to journalArticle

Gerber, Steve L. ; Cantor, Louis ; Brater, D. Craig. / Systemic drug interactions with topical glaucoma medications. In: Survey of Ophthalmology. 1990 ; Vol. 35, No. 3. pp. 205-218.
@article{58e1363f5cda4b9d8c7b0336b748f2b7,
title = "Systemic drug interactions with topical glaucoma medications",
abstract = "Topically administered ophthalmic medications are capable of attaining clinically important serum concentrations, as evidenced by the variety of systemic side effects they can produce. These drugs are therefore also capable of interacting with other drugs administered orally and intravenously. This is especially important when medications are administered to an elderly population, who are often receiving multiple medications. The Physician's Desk Reference and the United States Pharmacopeia Drug Information directory contain numerous warnings of potential interactions between topical glaucoma medications and systemically administered drugs. Unfortunately, literature supporting such interactions is limited, both in quantity and quality, being anecdotal in many cases. This report summarizes available information regarding the nonocular interactions between topical ophthalmic glaucoma medications and other systemically administered medications. Clinical evidence of these interactions is lacking in many cases.",
keywords = "adrenergic agonist, beta-adrenergic antagonist, drug interactions, glaucoma medications, parasympathomimetic agent",
author = "Gerber, {Steve L.} and Louis Cantor and Brater, {D. Craig}",
year = "1990",
doi = "10.1016/0039-6257(90)90090-I",
language = "English",
volume = "35",
pages = "205--218",
journal = "Survey of Ophthalmology",
issn = "0039-6257",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Systemic drug interactions with topical glaucoma medications

AU - Gerber, Steve L.

AU - Cantor, Louis

AU - Brater, D. Craig

PY - 1990

Y1 - 1990

N2 - Topically administered ophthalmic medications are capable of attaining clinically important serum concentrations, as evidenced by the variety of systemic side effects they can produce. These drugs are therefore also capable of interacting with other drugs administered orally and intravenously. This is especially important when medications are administered to an elderly population, who are often receiving multiple medications. The Physician's Desk Reference and the United States Pharmacopeia Drug Information directory contain numerous warnings of potential interactions between topical glaucoma medications and systemically administered drugs. Unfortunately, literature supporting such interactions is limited, both in quantity and quality, being anecdotal in many cases. This report summarizes available information regarding the nonocular interactions between topical ophthalmic glaucoma medications and other systemically administered medications. Clinical evidence of these interactions is lacking in many cases.

AB - Topically administered ophthalmic medications are capable of attaining clinically important serum concentrations, as evidenced by the variety of systemic side effects they can produce. These drugs are therefore also capable of interacting with other drugs administered orally and intravenously. This is especially important when medications are administered to an elderly population, who are often receiving multiple medications. The Physician's Desk Reference and the United States Pharmacopeia Drug Information directory contain numerous warnings of potential interactions between topical glaucoma medications and systemically administered drugs. Unfortunately, literature supporting such interactions is limited, both in quantity and quality, being anecdotal in many cases. This report summarizes available information regarding the nonocular interactions between topical ophthalmic glaucoma medications and other systemically administered medications. Clinical evidence of these interactions is lacking in many cases.

KW - adrenergic agonist

KW - beta-adrenergic antagonist

KW - drug interactions

KW - glaucoma medications

KW - parasympathomimetic agent

UR - http://www.scopus.com/inward/record.url?scp=0025202514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025202514&partnerID=8YFLogxK

U2 - 10.1016/0039-6257(90)90090-I

DO - 10.1016/0039-6257(90)90090-I

M3 - Article

C2 - 1980380

AN - SCOPUS:0025202514

VL - 35

SP - 205

EP - 218

JO - Survey of Ophthalmology

JF - Survey of Ophthalmology

SN - 0039-6257

IS - 3

ER -